Apiam Animal Health (ASX:AHX) is comprised of Australia’s leading Production Animal and Mixed Animal veterinary practices.
Apiam Animal Health incorporates over 150 highly experienced, industry leading veterinarians with expertise across pig, dairy, feedlot, sheep, poultry, equine, and companion animal sectors, supported by an experienced administration, nursing, technical services and ancillary team.
Apiam Animal Health is fully vertically integrated, including having veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.
What sets Apiam apart is shared expertise and professional collaboration across the business.
We believe that local knowledge is global knowledge and apply this philosophy across all our businesses from vet clinic, to production animal consultancy, logistics and laboratory with our vets and allied staff sharing expertise and specialist knowledge.
We collaborate and consult across Apiam businesses to deliver the best outcomes for the animals in our care. We are focussed on meeting the needs of our clients and shaping the future of the industry to deliver best practice animal welfare at a local level and nationally.
The name Apiam Animal Health and the logo for the company were inspired by the honey bee, which belongs to the Genus Apis.
Bees are symbolic of a team working towards a common goal. They are seen as industrious, hard-working characteristics: creating wonderfully efficient, meticulous, hexagonal hives.
Hexagons form a repetitive pattern, common in nature due to scalability while maintaining their robustness and strength.
It is Apiam Animal Health’s goal that all clinics, businesses and employee’s will work together towards a common goal, developing its team and building a successful, inspiring and strong company.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Rural vet stock Apiam jumps 17pc on huge first half
News
Top 10 at 11: Half-year numbers speak for themselves as reporting season marches on
News
Pampered pets continue to boost ASX pet stocks, reporting solid half yearly results
News
Pampered pooches: Which ASX stocks are riding the ‘humanisation of pets’ trend?
Health & Biotech
ASX Health Stocks: Cynata races ahead after getting green light for diabetic foot ulcer clinical trial
Escrow Watch
Escrow Watch: Probiotics play Biome will release nearly a third of its shares in June
Health & Biotech
ASX Health Stocks: Cannabis play Little Green Pharma signs $7.5m German supply deal
Health & Biotech
Apiam makes two key acquisitions as it grows foothold in regional veterinary market
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Health & Biotech
Apiam expands presence in national animal health market with Equine Clinic acquisition
Health & Biotech
ASX Health Stocks: Apiam and Trajan on acquisition trail, Immutep provides updates on Phase 2 trials
Health & Biotech
ASX Health Stocks: Mesoblast jumps 10pc on Phase 3 trial results for chronic heart failure
Director Trades
Directors’ Trades: This week’s list of traders includes three noteworthy fund managers
Health & Biotech
Apiam confirms APVMA approval for a critical new vaccine in a major breakthrough for Australian cattle health
Health & Biotech
Apiam expands presence in key regional Victorian hub with acquisition of Horsham Veterinary Hospital
Health & Biotech
Dairy and mixed clinics boost Apiam’s solid start to FY22 as vet network closes key acquisitions
Health & Biotech